Authors
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Latest:
Are We Close To A Universal Flu Vaccine?Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.
Latest:
Psychiatric Pharmacist Working to Optimize Treatment, Improve Patient SafetyA conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.
Latest:
Apetamin Gains Popularity on Social Media as Weight Gain DrugApetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?
Latest:
Limitations Persist in Growth of Precision MedicineDespite breakthroughs for personalized medicine, barriers still exist in real-world application.
Latest:
Clascoterone Cream 1% for the Treatment of AcneClascoterone cream 1% is a first-in-class topical acne treatment that targets the androgen receptors in the skin.
Latest:
Recap: Pharmacists Share The Biggest Takeaways from APhA 2025Experts discuss what they learned at the American Pharmacists Association Annual Meeting and Exposition 2025.
Latest:
Pharmacists Play Large Role in Continuous Glucose Monitoring for Patients With Diabetes | APhA 2025Lindsey Miller, PharmD, clinical assistant professor of pharmacy practice at the University of Mississippi, discusses how pharmacists can help patients understand and effectively use continuous glucose monitoring.
Latest:
Adverse Effect Burdens of OCS, ICS Use in AsthmaAdverse effects of oral and inhaled corticosteroid use may impact quality of life for people with asthma.
Latest:
Cost Plus Drugs Making Deals with PayersMark Cuban’s Cost Plus Drugs business has entered into agreements with Capital Blue Cross and Rightway.
Latest:
Allergic Contact Dermatitis Remains Prevalent, Negatively Impacts Quality of LifeResearchers conducted a comprehensive review of allergic contact dermatitis, detailing the condition’s epidemiology, pathophysiology, clinical manifestations, diagnostic approaches, and therapeutic options.
Latest:
OTC Medications to Treat the Young AthleteA variety of nonprescription treatments, supplements, and patches can alleviate pain for children and adolescents.
Latest:
How Inappropriate Antibiotic Prescribing Harms PatientsAccording to a study, patients are frequently prescribed broad-spectrum antibiotics instead of narrowly tailored antibiotics, which would be more optimized to treat them.
Latest:
Reevaluating the Use of Silver Sulfadiazine Cream in the Management of BurnsOne antimicrobial agent commonly used in the management of burns is silver sulfadiazine.
Latest:
mRNA Technology Leads to Advances in HIV Vaccine CandidateResults of a recent preclinical study provide proof of concept that an mRNA HIV vaccine is safe, immunogenic, and induces CD4–T-cell responses.
Latest:
AI-Optimized Cash Pricing Can Help Pharmacies ThriveLearn how one pharmacy chain adopted a cash pricing solution that offered new opportunities for profitability while still offering competitive pricing to customers.
Latest:
Lantidra Cell Therapy for Type 1 Diabetes Approved by FDAThe approval was based on safety and efficacy data from 30 participants in 2 open-label, single-arm studies that received 1 to 3 infusions of donislecel.
Latest:
Examining the Risk of Tardive Dyskinesia from AntipsychoticsA recent study highlights the significant frequency of the adverse effect.
Latest:
Reevaluating the Use of Silver Sulfadiazine Cream in the Management of BurnsOne antimicrobial agent commonly used in the management of burns is silver sulfadiazine.
Latest:
Promising Therapies, Treatment Strategies for HR+ Breast Cancer | ASHP MidyearA conversation with Julia L. Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator of breast medical oncology for the Levine Cancer Institute at Atrium Health.
Latest:
Molnupiravir: Oral Antiviral for the Treatment of COVID-19Molnupiravir is an oral antiviral for the treatment of mild to moderate COVID-19 in adults at high risk of severe disease.
Latest:
What To Know: FDA Approves Apomorphine for Parkinson DiseaseExpert highlights the benefits of using apomorphine infusion to provide more consistent medication levels and reduce the unpredictable fluctuations.
Latest:
Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common ColdDespite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Latest:
Tips Pharmacists Can Use to Help Women Experiencing Depression | ASHP MidyearA conversation with Kathleen Vest, PharmD, BCACP, CDCES, FCCP, professor of Pharmacy Practice at Drake University College of Pharmacy and Health Sciences.
Latest:
Thermometers: A ReviewPharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.
Latest:
Virtual Self-Management Tools Can Reduce Blood Sugar in Type 2 DiabetesAll 3 types of virtual diabetes self-management interventions lead to better results in hemoglobin A1c over a 6-month period.
Latest:
FDA: Exblifep Approved for Complicated Urinary Tract InfectionsCefepime/enmetazobactam was granted a 5-year exclusivity extension under GAIN Act legislation.
Latest:
More Than Long COVID, There's Flu and Pneumonia TooEpic research suggests that like COVID-19, flu and other viral pneumonias can result in long-term symptoms like fatigue and brain fog. Why that might be is open question.
Latest:
Ethical, Practical Considerations of Exemptions to Employer Vaccine Mandates for AnxietyDoes anxiety justify an exemption from vaccine mandates among health care workers?
Latest:
FDA Grants Accelerated Approval to Lifileucel, First-Ever Immunotherapy For Unresectable, Metastatic MelanomaThe FDA's decision represents a landmark approval of a tumor-derived cellular therapy in a solid tumor cancer.
